Effects of diazoxide and a dipyridamole derivative on cardiac nucleotide content.
Maxwell
G M
GM
D000244:Adenosine Diphosphate / Q000737:chemistry; D000249:Adenosine Monophosphate / Q000737:chemistry; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D003981:Diazoxide / Q000737:chemistry* / Q000494:pharmacology; D004176:Dipyridamole / Q000031:analogs & derivatives / Q000737:chemistry*; D006321:Heart / Q000187:drug effects*; D009025:Morpholines / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism*; D009711:Nucleotides / Q000737:chemistry*; D051381:Rats; D017208:Rats, Wistar
D009025:Morpholines; D009711:Nucleotides; C006043:RE 102; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D000242:Cyclic AMP; D003981:Diazoxide